| CTRI Number |
CTRI/2024/04/065005 [Registered on: 01/04/2024] Trial Registered Prospectively |
| Last Modified On: |
21/03/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
Development of biological dressing for wound management of acute burns and trauma |
|
Scientific Title of Study
|
Development of cell-laden 3D scaffold for wound management of acute burns and trauma |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Mathew Peter |
| Designation |
Assistant Professor |
| Affiliation |
Manipal Institute of Technology, Manipal |
| Address |
Department of biomedical Engineering, Manipal Institute of Technology, Manipal 576104
Udupi KARNATAKA 576104 India |
| Phone |
9322428766 |
| Fax |
|
| Email |
mathew.peter@manipal.edu |
|
Details of Contact Person Scientific Query
|
| Name |
Mathew Peter |
| Designation |
Assistant Professor |
| Affiliation |
Manipal Institute of Technology, Manipal |
| Address |
Department of biomedical Engineering, Manipal Institute of Technology, Manipal 576104
KARNATAKA 576104 India |
| Phone |
9322428766 |
| Fax |
|
| Email |
mathew.peter@manipal.edu |
|
Details of Contact Person Public Query
|
| Name |
Mathew Peter |
| Designation |
Assistant Professor |
| Affiliation |
Manipal Institute of Technology, Manipal |
| Address |
Department of biomedical Engineering, Manipal Institute of Technology, Manipal 576104
KARNATAKA 576104 India |
| Phone |
9322428766 |
| Fax |
|
| Email |
mathew.peter@manipal.edu |
|
|
Source of Monetary or Material Support
|
| Ktech Elevate Grant 2023
Address: 85, Kengal Hanumanthaiah Rd, NGO Colony, Sudhama Nagar, Bengaluru, Karnataka 560027 |
| MSME Hackathan Grant 2022
Address: Room No 468 C, Udyog Bhawan, Rafi Marg, New Delhi - 110011 |
|
|
Primary Sponsor
|
| Name |
Kasturba Medical College Manipal |
| Address |
Tiger Circle Road, Madhav Nagar Eshwar Nagar Manipal Karnataka 576104 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Mathew Peter |
Manipal Institute of Technology Manipal |
Department of Biomedical Engineering, Manipal Institute of Technology MAHE Udupi KARNATAKA |
9322428766
mathew.peter@manipal.edu |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Kasturba Medical College/Kasturba Hospital Institutional Ethical Committee (KMC/KH IEC) |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery, (2) ICD-10 Condition: L987||Excessive and redundant skin and subcutaneous tissue, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients undergoing liposuction or C-section as a delivery or treatment for various diseases and non-disease conditions chiefly as a contouring procedure. The umbilical cord or the liposuction aspirate is the discarded waste product of the procedure that will be used in study. |
|
| ExclusionCriteria |
| Details |
Patients with blood related disorders |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Samples from 20 patients undergoing plastic surgery (liposuction) or C-section delivery will be recruited for the study |
24 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Blood sample procurement from patient for phenotype & genotype characterization |
24 months |
|
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/05/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
In our project, we will focus on developing a wound dressing with
allogeneic mesenchymal stem cell-laden biocompatible hydrogel that has the potential to
incorporate onto the body and accelerate and optimise healing and even potentially become
a substitute for autologous skin grafts. The innovation in this project relies on the
development of a hydrogel sheet containing cell-laden allogenic Mesenchymal Stem Cells to
promote active wound healing and wound closure in traumatic wound. Hydrogel provides a
moist environment around the wound site which is ideal for extensive healing for both
exudating and necrotic wounds. The role of Mesenchymal Stem Cells in wound healing has a
promising outcome and has been researched extensively in the last few decades. Moreover,
allogeneic-MSCs have been shown to evade immune rejection by the host as they express
very low levels of MHC class I, no MHC class II and do not induce activation of allogeneic
lymphocytes. It also has greater regenerative and wound closure properties than other skin
cell types like fibroblast and keratinocyte by inducing re-epithelisation and angiogenesis. |